Название документа

Pharmacological properties

Docsilamin (n, n-dimethyl-2 [1-phenyl-1 (piridinit) etoks] ethanolamine) — somnolent means of a class of ethanolamines from group of blockers of histamine h1-receptors, renders sedative and m-holinoblokiruyushchee action. reduces backfilling time, increases duration and sleep quality, at the same time does not change phase structure of a dream.

succinate is well soaked up by Docsilamin's

from a digestive tract, biotransformation is carried out in a liver. The main part of a docsilamin (about 60%) is removed in not changed view with urine, a part — with a stake.

Indication

Insomnia and other sleep disorders.

Use

by

is Appointed only to adults and teenagers 15 years, on 1 tablet in 15–30 min. prior to a dream are more senior. depending on individual reaction of the patient the dose of medicine can be lowered up to 1/2 tablets or to raise to 2 tablets.

Contraindication

Glaucoma, violations from an urethra and a prostate, the feeding period a breast (at administration of medicament it is necessary to stop breastfeeding), age up to 15 years, hypersensitivity to drug.

Side effects

Are connected by

with holinoblokiruyushchy effect of medicine — feeling of dryness in a mouth, accommodation violation, a lock, the complicated urination (especially at patients with tendency to these phenomena).

Special instructions

apply

With care at diseases of lungs. it is not necessary to appoint to drivers of transport (decrease in attention, drowsiness).

by

Interaction

At simultaneous application with barbiturates, benzodiazepines, a clonidine, opioid analgetics, neuroleptics, tranquilizers observes strengthening of overwhelming action on central nervous system. at a concomitant use of a sondoks with atropine or other blockers of m-holinoretseptorov the risk of emergence of anticholinergic by-effects increases: dryness in a mouth, the complicated urination. alcohol strengthens sedative action of a docsilamin that can make unsafe driving of vehicles and work with potentially dangerous mechanisms.

Overdose

Is possible

only at reception in very high doses. symptoms: mydriasis, dermahemia of the person, hyperthermia, excitement, lacks of coordination, shiver, athetotic movements, spasms. in the absence of treatment the coma which is followed by collapse can develop.

symptomatic treatment. According to indications use anticonvulsant medicaments and carry out IVL.

Storage conditions

B the dry, protected from light place.

Characteristics
Active ingredients Docsilamin
Amount of active ingredient 15 mg
Applicant Red star
Code of automatic telephone exchange N05CM Other hypnotic drugs and sedatives
Interaction with food It doesn't matter
Light sensitivity Not sensitive
Market status Generic-generic
Origin Chemical
Prescription status Without prescription
Primary packing blister
Producer Z_RKA THE STALEMATE H_MZAVOD IS RED
Quantity in packing 30 tablets (3 blisters on 10 pieces)
Release form tablets for internal use
Route of administration Oral
Sign Domestic
Storage temperature from 5 °C to 25 °C
Trade name Sondoks

Reviews Sondoks tab. of 0.015 g No. 30

5 Rating 1 Reviews

Quality
Speed
Delivery
Performance
Price

Sondoks tab. of 0.015 g No. 30

  • Product Code: 178165
  • In Stock

  • Ready to ship
  • $20.33


Related Products

Last Viewed

Модули для Opencart